Per Gisle Djupesland
Gründer bei OptiNose US, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Peter Kaighn Miller | M | 62 |
OptiNose US, Inc.
 OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA.
Optinose AS
 Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | 15 Jahre |
| Helena Kyttari Djupesland | F | - |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway.
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 24 Jahre |
| Ramy Mahmoud | M | 59 |
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 14 Jahre |
| Joseph Scodari | M | 71 |
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 7 Jahre |
| Sandra Helton | F | 74 |
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 6 Jahre |
| Sriram Venkataraman | M | 51 |
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 14 Jahre |
| Anthony Flint | M | - |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | - |
| Michael Marino | M | 48 |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | 6 Jahre |
| Catherine Owen | F | 53 |
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bill Doyle | M | 61 |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway.
OptiNose US, Inc.
OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | 6 Jahre |
| Øystein Moan | M | 65 |
University of Oslo
| 1 Jahre |
| Terje Osmundsen | M | - |
University of Oslo
| 6 Jahre |
| Einar Christen Lange | M | 82 |
University of Oslo
| 3 Jahre |
| Rolv Eitrem Heggenhougen | M | - |
University of Oslo
| 3 Jahre |
| Eystein Setsaas | M | 72 |
University of Oslo
| 3 Jahre |
| Kjell Rusti | M | - |
University of Oslo
| 4 Jahre |
| Geir Claussen | M | - |
University of Oslo
| 4 Jahre |
| Svein J. Ruud Johansen | M | - |
University of Oslo
| 3 Jahre |
| Kjersti Gravningen | F | - |
University of Oslo
| 4 Jahre |
| Anders Christian Ryssdal | M | 69 |
University of Oslo
| 3 Jahre |
| Tone Bjørnov | F | 62 |
University of Oslo
| 2 Jahre |
| Ivar Gimse | M | - |
University of Oslo
| 1 Jahre |
| Jon Nicolaisen | M | 65 |
University of Oslo
| 4 Jahre |
| Erik Berg Solheim | M | 69 |
University of Oslo
| 4 Jahre |
| Olav Jarlsby | M | - |
University of Oslo
| 3 Jahre |
| Runar Sandanger | M | 67 |
University of Oslo
| 1 Jahre |
| Aage Stori | M | - |
University of Oslo
| 3 Jahre |
| Anne-Lise Aukner | F | 68 |
University of Oslo
| 3 Jahre |
| Larry G. Pickering | M | 81 |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | - |
| Hilde Furberg | F | 65 |
University of Oslo
| 1 Jahre |
| Terje V. Arnesen | M | - |
University of Oslo
| 4 Jahre |
| Liselott Kilaas | F | 65 |
University of Oslo
| 1 Jahre |
| Roderick Hafner | M | 58 |
Optinose AS
Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | - |
| Thomas Ramdahl | M | 68 |
University of Oslo
| 3 Jahre |
| Hilde Myrberg | F | 66 |
University of Oslo
| 3 Jahre |
| Alf Bjørseth | M | 83 |
University of Oslo
| 3 Jahre |
| Morten Opstad | M | 71 |
University of Oslo
| 3 Jahre |
| Christian Andreas Beck | M | 68 |
University of Oslo
| 3 Jahre |
| Svein Ilebekk | M | 70 |
University of Oslo
| 1 Jahre |
| Odd Gleditsch | M | - |
University of Oslo
| 3 Jahre |
| Arvid Grundekjøn | M | 69 |
University of Oslo
| 3 Jahre |
| Yngve Slyngstad | M | 62 |
University of Oslo
| 3 Jahre |
| Luis Luna | M | - |
University of Oslo
| - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Norwegen | 38 | 88,37% |
| Vereinigte Staaten | 8 | 18,60% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Per Gisle Djupesland
- Persönliches Netzwerk